bronchiectasi
common
featur
sever
inherit
acquir
pulmonari
diseas
condit
among
inherit
diseas
cystic
fibrosi
cf
major
disord
associ
bronchiectasi
acquir
condit
frequent
featur
bronchiectasi
includ
postinfect
bronchiectasi
chronic
obstruct
pulmonari
diseas
copd
mechanist
bronchiectasi
driven
complex
interplay
inflamm
infect
neutrophil
inflamm
play
predomin
role
clinic
character
manag
bronchiectasi
involv
precis
diagnost
workup
tailor
therapeut
strategi
pulmonari
imag
becom
essenti
tool
diagnosi
followup
bronchiectasi
prospect
futur
studi
requir
optim
diagnost
therapeut
manag
bronchiectasi
particularli
heterogen
noncf
bronchiectasi
popul
bronchiectasi
condit
area
bronchial
lumen
perman
abnorm
widen
accompani
infect
bronchiectasi
found
varieti
pulmonari
diseas
genet
caus
acquir
sever
pulmonari
infect
cystic
fibrosi
cf
also
featur
kartagen
syndrom
chronic
obstruct
pulmonari
diseas
copd
alpha
defici
asthma
primari
immunodefici
bronchietasi
caus
longterm
excess
inflammatori
damag
airway
result
tissu
breakdown
enlarg
affect
airway
key
clinic
symptom
chronic
product
cough
short
breath
global
half
case
caus
identifi
idiopath
case
togeth
sever
known
aetiolog
postinfecti
allerg
hypersensit
collect
fall
categori
noncyst
fibrosi
noncf
bronchiectasi
discuss
key
featur
cf
noncf
relat
bronchiectasi
respect
pathogenesi
imag
clinic
manag
bronchiectasi
mechanist
result
chronic
inflammatori
microenviron
trigger
airway
tissu
breakdown
cf
noncf
bronchiectasi
complex
interplay
infect
inflamm
feed
proinflammatori
viciou
circl
progress
drive
gener
bronchiectasi
destruct
pulmonari
architectur
inflammatori
immun
cell
mainli
activ
macrophag
neutrophil
repres
major
infiltr
popul
diseas
condit
associ
bronchiectasi
contribut
significantli
tissu
damag
bronchiectasi
gener
releas
harm
cellular
ingredi
particularli
cellderiv
proteas
reactiv
oxygen
speci
repres
key
mediat
degrad
destruct
extracellular
pulmonari
tissu
compon
lead
bronchiectasi
format
precis
earli
immunemedi
mechan
trigger
maintain
format
bronchiectasi
remain
yet
incomplet
understood
regul
immun
homeostasi
seem
essenti
sinc
immun
defici
well
hyperact
immun
respons
associ
bronchiectasi
particularli
proteaseantiproteas
imbal
found
cf
copd
airway
consid
key
pathogen
compon
degrad
extracellular
matrix
mutat
cystic
fibrosi
transmembran
conduct
regul
cftr
gene
caus
cf
lung
diseas
drive
earliest
pathogen
event
epitheli
cell
ultim
lead
genesi
bronchiectasi
also
beyond
cf
lung
diseas
cftrrelat
cellular
mechan
regul
mucociliari
clearanc
involv
cigarett
smokeinduc
copd
follow
two
section
focu
microbiolog
immunologicalinflammatori
b
find
associ
pathogenesi
bronchiectasi
pseudomona
aeruginosa
common
domin
pathogen
found
airway
cf
noncf
bronchiectasi
patient
chronic
infect
associ
sever
declin
lung
function
increas
hospit
frequent
exacerb
diseas
sever
although
clinic
manifest
two
set
vari
core
airway
microbiota
larg
analog
along
pseudomona
bacteria
belong
genera
haemophilu
streptococcu
staphylococcu
veillonella
prevotella
achromobact
also
make
core
microbiota
observ
bronchiectasi
interestingli
p
aeruginosa
h
influenza
describ
competit
inhibit
turn
alter
core
microbiota
noncf
bronchiectasi
airway
nontubercul
mycobacteria
ntm
form
anoth
signific
group
pathogen
colon
cf
noncf
airway
mycobacterium
avium
complex
mac
mycobacterium
abscessu
frequent
isol
cf
high
rate
multidrug
resist
speci
make
notori
difficult
treat
ntm
belong
mac
group
also
highli
preval
noncf
bronchiectasi
femal
preponder
group
organ
surprisingli
poorli
associ
diseas
sever
exacerb
noncf
set
compar
pseudomona
contrast
cf
patient
mac
abscessu
often
associ
aggress
acceler
lung
function
declin
interestingli
bacteri
popul
drastic
chang
stabl
exacerb
state
bronchiectasi
howev
viral
load
posit
correl
exacerb
cf
noncf
bronchiectasi
patient
infect
virus
belong
coronaviru
rhinoviru
influenza
ab
viru
famili
frequent
detect
exacerb
bronchiectasi
whether
occurr
virus
form
part
airway
virom
bronchiectasi
caus
consequ
exacerb
remain
elucid
attent
toward
understand
microbiom
bronchiectasi
direct
bacteriom
although
fungi
frequent
isol
airway
role
pulmonari
mycobiom
pathogenesi
diseas
state
remain
larg
elus
filament
fungi
belong
genu
aspergillu
frequent
isol
fungal
organ
sputum
sampl
cf
patient
among
differ
speci
aspergillu
fumigatu
common
chronic
colon
cf
allerg
bronchopulmonari
aspergillosi
abpa
allerg
aspergillusassoci
diseas
frequent
comorbid
cf
aspergillu
colon
sensit
also
independ
correl
lung
function
declin
radiolog
sever
cf
singl
studi
date
shown
fungi
belong
aspergillu
spp
candida
albican
also
identifi
airway
noncf
bronchiectasi
patient
importantli
studi
sever
asthma
patient
aspergillu
fumigatu
sensit
also
associ
poorer
lung
function
increas
incid
bronchiectasi
like
caus
consequ
anatom
airway
distort
among
yeast
candida
spp
frequent
colon
bronchiectat
airway
isol
candida
albican
airway
shown
predictor
frequent
hospitalexacerb
declin
lung
function
compar
bacteria
present
understand
fungal
pathogenesi
context
cf
noncf
bronchiectasi
remain
limit
work
requir
determin
preval
colon
frequenc
hostpathogen
interact
risk
factor
profil
key
patient
group
neutrophildomin
inflamm
key
featur
bronchiectasi
sputum
neutrophil
higher
bronchiectasi
patient
versu
healthi
control
correl
increas
diseas
sever
key
chemoattract
requir
migrat
infiltr
neutrophil
bronchiectat
airway
high
system
level
detect
individu
bronchiectasi
antibacteri
neutrophil
respons
reactiv
oxygen
speci
ro
format
activ
axi
proteolyt
cleavag
mediat
neutrophil
elastas
ne
associ
exacerb
lung
function
declin
bronchiectasi
impair
antibacteri
neutrophil
function
uncontrol
ne
activ
found
cf
airway
caus
respiratori
tissu
damag
degrad
extracellular
protein
surfact
protein
cellular
surfac
receptor
complement
receptor
high
ne
level
correl
diseas
sever
poorer
lung
function
describ
cf
noncf
bronchiectasi
set
context
cxcr
receptor
antagonist
hypothes
inhibit
neutrophil
airway
influx
shown
effect
modul
inflammatori
state
bronchiectasi
airway
neutrophil
cf
illustr
impair
phagocyt
abil
line
observ
cf
neutrophil
impair
ro
product
critic
mediat
antimicrobi
host
defens
neutrophil
defect
oxid
abil
obtain
noncf
bronchiectasi
patient
poorer
bacteri
kill
compar
healthi
control
serin
proteas
also
import
neutrophil
deriv
product
releas
respons
signal
degrad
proteoglycan
respiratori
epithelium
subsequ
induc
airway
damag
bronchiectasi
activ
airway
neutrophil
secret
abund
human
neutrophil
peptid
hnp
describ
inhibit
phagocyt
abil
importantli
high
concentr
hnp
detect
cf
noncf
airway
turn
may
contribut
decreas
phagocyt
abil
higher
rate
infect
describ
condit
poorer
clearanc
neutrophil
alveolar
macrophag
augment
inflammatori
state
bronchiectasi
eosinophil
contribut
tissu
injuri
cf
presenc
eosinophil
cation
protein
ecp
herald
cell
activ
state
ecp
level
elev
airway
system
bronchiectasi
eosinophil
marker
includ
eosinophil
protein
x
peroxidas
follow
similar
pattern
like
ecp
contribut
poorer
pulmonari
function
importantli
eosinophil
granul
releas
cf
may
trigger
ne
illustr
crossgranulocyt
talk
occur
set
bronchiectasi
tcell
constitut
anoth
key
compon
inflammatori
respons
bronchiectasi
cf
high
thelper
respons
observ
cytokin
correl
decreas
pulmonari
function
cfpseudomonascolon
patient
cell
neutrophil
nkt
cell
found
abund
allcaus
bronchiectasi
compar
healthi
control
high
infiltr
independ
associ
poorer
lung
function
cf
activ
antigenspecif
pathway
describ
noncf
bronchiectasi
central
mediat
pathway
lack
correl
bronchiectasi
diseas
phenotyp
suggest
promin
role
neutrophilmedi
inflamm
like
play
pathogenesi
bronchiectasi
cell
nkt
express
proinflammatori
describ
paediatr
bronchiectasi
common
proinflammatori
marker
ne
matrix
metalloproteinas
elev
bronchiectasi
latter
two
indic
poorer
prognost
outcom
semin
studi
cf
children
identifi
key
risk
factor
bronchiectasi
show
elev
airway
neutrophil
elastas
activ
major
risk
factor
predict
bronchiectasi
develop
bacteri
load
noncf
bronchiectasi
correl
increas
airway
ne
system
eselectin
deriv
inflammatori
marker
phenomena
confirm
vitro
use
bronchial
epitheli
cell
line
treat
sputum
bronchiectasi
patient
exacerb
cf
noncf
bronchiectasi
increas
inflamm
irrespect
bacteri
viral
fungal
causat
interestingli
novel
inflammatori
marker
describ
varieti
pulmonari
diseas
state
includ
copd
also
identifi
children
cfand
hivrel
bronchiectasi
although
concentr
latter
set
highest
high
level
correl
close
lung
function
declin
futur
studi
explor
level
bronchiectasi
aetiolog
better
understand
role
pathogenesi
bronchiectasi
vitamind
defici
observ
cf
associ
increas
bacteri
infect
exacerb
poorer
lung
function
corrobor
noncf
bronchiectasi
indic
diseas
sever
associ
infect
bacteri
colon
airway
inflamm
consequ
frequent
exacerb
bronchietasi
patient
clinic
character
sputum
product
upon
exercis
spontan
lead
product
cough
mucopurul
mass
yellowish
greenish
brown
sputum
morn
day
howev
bronchiectasi
mainli
detect
time
point
irrevers
structur
damag
alreadi
done
airway
architectur
bronchiectasi
initi
may
revers
children
later
probabl
major
genet
diseas
associ
bronchiectasi
includ
cf
primari
ciliari
dyskinesia
pcd
kartagen
syndrom
alpha
defici
primari
immunodefici
rare
disord
like
williamscampbel
syndrom
marfan
syndrom
major
acquir
caus
sever
bacteri
infect
tuberculosi
staphylococcu
klebsiella
other
postinfecti
bronchiol
obliteran
notabl
also
fungal
infect
lead
bronchiectasi
particularli
abpa
chronic
aspergillu
fumigatuscaus
pulmonari
condit
base
essenti
clinic
workup
patient
featur
bronchiectasi
screen
congenit
acquir
condit
order
tailor
appropri
treatment
attenu
diseas
progress
prevent
manner
key
mention
condit
diagnos
monitor
pulmonari
symptom
structur
chang
use
pulmonari
function
test
highresolut
comput
tomographi
hrct
avoid
establish
bronchiectasisrel
diseas
end
help
follow
concept
introduc
previous
classifi
form
bronchiti
children
acut
bronchiti
usual
trigger
viral
infect
resolv
within
day
one
two
week
sometimesfor
mani
reason
unknownsymptom
resolv
spontan
persist
state
call
protract
bacteri
bronchiti
pbb
pbb
initi
establish
pediatr
current
public
discuss
transfer
concept
adult
bir
gibson
martin
pbb
differenti
variou
form
depend
tool
use
diagnos
pbb
character
base
differ
stratifi
base
concept
believ
left
untreat
fraction
pbb
progress
chronic
suppur
lung
diseas
csld
radiolog
confirm
bronchiectasi
fig
csld
differ
bronchiectasi
lack
radiograph
sign
bronchiectasi
hrct
scan
clinic
csld
diagnos
children
whose
chronic
wet
cough
resolv
oral
antibiot
caus
exclud
although
proven
formal
caus
bronchiectasi
sequenc
progress
pbb
csld
bronchiectasi
highli
like
need
substanti
prospect
studi
interest
recent
find
otherwis
healthi
children
pbb
children
bronchiectasi
children
cf
share
similar
core
airway
microbiota
pattern
h
influenza
make
greatest
contribut
observ
similar
microbiota
adult
cf
bronchiectasi
significantli
differ
author
conclud
chronic
airway
infect
start
similarli
defect
airway
clearanc
time
intervent
host
factor
ie
underli
caus
progress
diverg
preval
bronchiectasi
children
cf
recent
assess
studi
conduct
australian
respiratori
earli
surveil
team
cystic
fibrosi
arest
cf
other
although
cf
patient
ctdefin
bronchiectasi
year
age
young
children
isol
ie
local
diseas
mildest
sever
lung
abnorm
lobar
diseas
extent
well
hand
clear
establish
bronchiectasi
persist
andor
progress
despit
current
optim
standardofcar
therapi
young
children
current
great
effort
undertaken
close
diagnost
gap
year
age
noninvas
assess
extent
lung
diseas
pragmacf
score
develop
sensit
reproduc
outcom
measur
assess
extent
lung
diseas
young
children
cf
moreov
lung
clearanc
index
measur
ventil
distribut
obtain
multiplebreath
washout
techniqu
sever
studi
shown
sensit
airway
diseas
cf
bronchial
diseas
howev
infant
cf
lung
clearanc
index
insensit
structur
diseas
assess
pragma
score
preschool
schoolag
children
cf
lung
clearanc
index
correl
total
diseas
extent
interest
good
posit
predict
valu
poor
neg
predict
valu
detect
bronchiectasi
therefor
lung
clearanc
index
may
good
surveil
tool
monitor
structur
lung
diseas
schoolag
cf
effort
identifi
precedingstag
bronchiectasi
cf
children
use
least
four
consecut
biennial
volumetr
ct
area
bronchiectasi
ct
scan
mark
analyz
associ
potenti
prestag
mucu
plug
airway
wall
thicken
atelectasisconsolid
basic
clinic
manag
bronchiectasi
includ
tailor
antimicrobi
therapi
airway
clearanc
techniqu
latter
includ
mucolyt
hyperton
salin
rhdna
well
chest
physiotherapi
vigor
physic
sport
activ
pbb
oral
antibiot
week
sever
month
describ
help
antibiot
commonli
use
clinic
includ
amoxicillin
amoxicillinclavulan
second
gener
cephalosporin
particularli
patient
cf
gramneg
organ
treat
inhal
tobramycin
colistin
actreonam
levofloxacin
well
oral
inhibitor
gyras
ie
ciprofloxacin
durat
treatment
guid
symptom
goal
symptomfre
patient
mostli
achiev
young
children
patient
stage
pbb
csld
earli
stage
bronchiectasi
specif
treatment
strategi
bronchiectasi
depend
underli
etiolog
includ
protein
augment
alpha
defici
antiallerg
approach
asthmaabpa
andor
immunoglobulin
substitut
immunodefici
detect
character
bronchiectasi
domain
thinsect
comput
tomographi
ct
highresolut
ct
hrct
mm
slice
thick
serv
refer
standard
imag
howev
pulmonari
mri
gain
interest
due
possibl
function
imag
without
radiat
burden
moreov
new
technic
develop
overcom
limit
low
mrsignal
low
spatial
resolut
cf
standard
report
use
score
autom
quantif
essenti
requisit
measur
track
find
particularli
result
focu
risk
stratif
context
bronchiectasi
one
import
imag
marker
gener
correl
clinic
outcom
bronchiectasi
defin
irrevers
dilat
bronchi
cylindr
varicos
cystic
morpholog
appear
cf
often
associ
mucu
plug
bronchial
wall
thicken
small
airway
diseas
radiolog
evalu
bronchiectasi
base
definit
publish
term
thorac
imag
fleischner
societi
morpholog
criteria
thinsect
ct
scan
includ
bronchial
dilat
respect
accompani
pulmonari
arteri
signet
ring
sign
lack
taper
bronchi
identif
bronchi
within
cm
pleural
surfac
socal
signet
ring
sign
primari
sign
bronchiectasi
repres
ringshap
opac
wherea
smaller
adjac
arteri
stay
signet
accord
concept
extent
bronchial
dilat
quantifi
use
ratio
bronchi
vessel
approach
challeng
recent
pediatr
studi
hrct
bronchial
tree
visibl
gener
ct
find
like
treeinbud
sign
centrilobular
opac
link
small
airway
diseas
dilat
inflamm
ronchiol
mucu
plug
peripheri
fig
differ
cf
bronchiectasi
depend
pancrea
insuffici
pi
pi
patient
illustr
sever
bronchiectasi
primari
ciliari
dyskinesia
pcd
patient
similar
ct
score
pancreaticsuffici
ps
cf
patient
contrast
cf
correl
structur
chang
clinic
paramet
detect
previou
studi
howev
recent
studi
adult
pcd
patient
cohort
indic
ct
find
relat
lung
function
chang
clear
identifi
prebronchiectasi
imag
howev
mucu
plug
shown
common
precursor
cf
imag
illustr
lung
damag
even
lung
function
forc
expiratori
volum
normal
fig
contrast
imag
pulmonari
function
test
pft
challeng
young
children
complementari
role
lung
clearanc
index
lci
describ
regard
evalu
presenc
extent
bronchiectasi
ct
imag
accept
sensit
reproduc
modal
date
use
new
gener
dual
sourc
multidetector
ct
mdct
maintain
subsecond
acquisit
whole
lung
breath
pulsat
artifact
neglig
even
young
children
sedat
need
final
use
spectral
beam
shape
iter
reconstruct
algorithm
ultralowdos
pediatr
chest
ct
realiz
effect
dose
msv
condit
therefor
challeng
routin
use
mri
hand
coupl
reason
support
mri
radiat
burden
routin
perform
volumetr
chest
ct
may
mani
time
higher
third
gener
dual
sourc
ct
recent
publish
increment
hrct
signific
gap
lower
dose
also
diagnost
perform
lead
motion
artifact
pediatr
popul
estim
risk
radiationinduc
cancer
pediatr
chest
ct
small
neglig
particularli
case
repeat
exposur
mri
side
effect
radiat
enabl
longterm
surveil
lung
damag
overal
diagnost
perform
score
evalu
mri
direct
comparison
ct
good
excel
fig
moreov
apart
polar
helium
imag
function
imag
easili
implement
use
perfus
ventil
weight
standard
proton
mri
assess
small
airway
diseas
fig
standard
report
crosssect
imag
score
system
suitabl
sever
reason
assess
quantifi
individu
progress
lung
damag
comparison
complementari
lung
function
test
b
use
total
partial
score
valu
endpoint
intervent
studi
c
establish
predict
imag
biomark
ct
score
system
use
semiquantit
scale
extent
sever
specif
find
either
base
lobe
involv
bronchopulmonari
segment
use
overlay
grid
accord
diseasespecif
preval
imag
abnorm
subscor
bronchiectasi
bronchial
wall
thicken
heavili
weight
interobserv
intraobserv
agreement
common
ct
score
shown
good
excel
compar
reproduc
also
found
mri
use
ct
mrspecif
adapt
score
system
small
number
studi
semiautomat
evalu
bronchi
dimens
excel
interobserv
agreement
found
particularli
bronchial
lumen
hand
mucu
obscur
mimic
bronchial
wall
thicken
apart
reproduc
weight
abnorm
within
score
valid
even
challeng
relat
purpos
use
score
eg
intervent
clinic
studi
aforement
imag
sensit
particularli
mild
diseas
assess
diseas
progress
context
score
bronchiectasi
particularli
lung
peripheri
import
wherea
air
trap
mosaic
perfus
mucu
plug
seem
sensit
marker
ct
mri
detect
effect
intervent
role
bronchiectasi
robust
predict
marker
shown
sever
longitudin
observ
extent
bronchiectasi
baselin
predict
number
respiratori
tract
exacerb
rte
chang
subscor
two
year
follow
strongli
associ
number
rte
provid
valu
similarli
describ
decad
long
observ
studi
older
studi
maximum
combin
score
bronchiectasi
emphysema
hrct
indic
poorer
prognosi
recent
studi
patient
sever
lung
diseas
await
lung
transplant
combin
score
bronchiectasi
bronchial
wall
thicken
mucu
consolid
associ
mortal
bronchiectasi
heterogen
complex
condit
remain
challeng
diagnost
therapeut
strategi
pathomechan
pulmonari
compart
share
common
microbiolog
immunolog
perspect
clinic
implic
treatment
approach
remain
challeng
individu
depend
underli
diseas
infect
statu
highresolut
imag
revolution
diagnosi
monitor
bronchiectasi
pave
way
precis
understand
diseas
pathogenesi
treatment
respons
futur
therapeut
lesson
learn
wellknown
phenotyp
cf
bronchiectasi
increasingli
transfer
multifacet
genotyp
phenotyp
noncf
bronchiectasi
airway
infect
treat
inhal
system
antibiot
mucu
clearanc
improv
inhal
therapi
chest
physiotherapi
wherea
specif
antiinflammatori
approach
still
clinic
establish
prospect
futur
studi
urgent
need
optim
diagnost
therapeut
manag
bronchiectasi
particularli
children
noncf
bronchiectasi
indic
high
unmet
medic
need
ethic
approv
consent
particip
applic
consent
public
obtain
person
includ
imag
sanjay
chotirmal
member
editori
board
section
editor
dominik
hartl
affili
univers
roch
basel
